Use of Dopamine Agonist Pergolide in Outpatient Treatment of Cocaine Dependence

REFERENCES

• APA (American Psychiatric Association). Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Press, Washington 1994; 175–272
   Google Scholar
• Araújo M. R., Laranjeira R., Dunn J. Cocaína: bases biológicas da administração, abstinência e tratamento (Cocaine: biological basis of administration, withdrawal and treatment). J. Bras. Psiq. 1998; 47: 497–511
   Google Scholar
• Barber W. S., O' Brien C. P. Pharmacotherapies. Addictions—a comprehensive guidebook, B. S. McCrady, E. E. Epstein. Oxford University Press, New York 1999; 347–69
   Google Scholar
• Basile L. F. H., Leite M. C. Circuitos encefálicos e abuso e dependência de cocaína (Encephalic circuits and cocaine abuse and dependence). Cocaina e crack: dos fundamentos ao tratamento (Cocaine and crack: from fundamentals to treatment), M. C. Leite, A. G. Andrade. Artes Médicas, Porto Alegre 1999; p. 72
   Google Scholar
• De Vries T. J., Schoffelmeer A N. M., Binnekade R., Vanderschuren L. J. M. J. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV self-administration. Psychopharmacol 1999; 143: 254–60, [CROSSREF]
   Web of Science ®Google Scholar
• Finney J. W., Moos R. H., Timko C. The course of treated and untreated substance use disorders: remission and resolution, relapse and mortality. Addictions—a comprehensive guidebook, B. S. McCrady, E. E. Epstein. Oxford University Press, New York 1999; 30–49
   Google Scholar
• Gawin F., Riordan C., Kleber H. Methilphenidate treatment of cocaine abusers without Attention Deficit Disorder: a negative report. Am. J. Drug Alcohol Abuse 1985; 11: 193–7, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gawin F., Kleber H. Pharmacological treatments of cocaine abuse. Psychiatr. Clin. North Am. 1986; 9: 573–83, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Halikas J. A., Kuhn K. L., Crosby R., Carlson G., Crea F. The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale. Compr. Psychiatry 1991; 32: 22–7, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Halikas J. A., Crosby R. D., Pearson V. L., Graves N. M. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse. Clin. Pharmacol. Ther. 1997; 62: 89–105, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiat. 1960; 23: 56–62, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Haney M., Foltin R. W., Fischman M. W. Effects of pergolide on intravenous cocaine self-administration in men and women. Psychopharmacology 1998; 137: 15–24, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Langtry H. D., Clissold S. P. Pergolide—a review of its pharmacological properties and therapeutic potential in Parkinson's disease. Drugs 1990; 39: 491–506, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Levin F. R., McDowellD., Evans S. M., Brooks D., Spano C., Nunes E. V. Pergolide mesilate for cocaine abuse: A controlled preliminary trial. Am. J. Addict 1999; 8: 120–7, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Lingjaerde O., Ahlfors U. G., Bech P., Dencker S. J., Elgen K. The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic treated patients. Acta Psychiatr. Scand. 1987; 76: 1–100
   PubMed Web of Science ®Google Scholar
• Malcolm R., Hutto B. R., Phillips J. D., Ballenger J. C. Pergolide mesilate treatment of cocaine withdrawal. J. Clin. Psychiatry 1991; 52: 39–40, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Malcolm R., Phillips J. D., Brady K. T., Roberts J. R. A comparison of pergolide and bromocriptine in the initial reabilitation of cocaine dependence. Am. J. Addict. 1994; 3: 144–50
   Web of Science ®Google Scholar
• Malcolm R., Moore J. W., Kajdasz D. K., Cochrane C. E. Pergolide mesilate: adverse effects occurring in the treatment of cocaine dependence. Am. J. Addict. 1997; 6: 117–23, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Malcolm R., Kajdasz D. K., Herron J., Anton R. F., Brady K. T. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend. 2000; 60: 61–8
   Google Scholar
• McCance E. F. Overview of potential treatment medications for cocaine dependence. Medication development for the treatment of cocaine dependence: Issues in clinical efficacy trials. NIDA Res. Monogr, B. Tai, N. Chiang, P. Bridge, 1997; 175: 36–72
   Google Scholar
• Mendelson J. H., Mello N. K. Management of cocaine abuse and dependence. N. Engl. J. Med. 1996; 334: 965–72, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Self D. W., Barnhart W. J., Lehman D. A., Nestler E. J. Opposite modulation of cocaineseeking behavior by D1 and D2-like dopamine receptor agonists. Science 1996; 271: 1586–9, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Washton A. M. Assessment. Cocaine Addiction: Treatment, Recovery and Relapse Prevention, A. M. Washton. W. W. Norton & Co, New York 1989; 79–97
   Google Scholar
• Weaver M. F., Schnoll S. H. Stimulants: Anphetamines and Cocaine. Addictions—A Comprehensive Guidebook, B. S. McCrady, E. E. Epstein. Oxford University Press, New York 1999; 105–20
   Google Scholar